Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 14 % of short-term debt in 2026; threshold 65 %.
Financials
Financial year 2026
RX FAVOREEL from Destelbergen, company number BE0783537096, closed financial year 2026 with a result of € 1.3 million after tax. For that financial year RX FAVOREEL recorded a gross margin of € 249,581 and equity of € 1,117. Compared with financial year 2025, the result moved from € 110,894 to € 1.3 million. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 1,117
▼ 99% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.3 million
▲ € 1.2 million vs 2025
Profit after tax over the fiscal year.
€ 9,341
▼ 92% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 1.5 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2026
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 34,356
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 3,738
▲ € 3,723 vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 38,021
▲ € 36,171 vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € -92 | € -2,357 | € -2,405 | € 249,581 | ▲ € 251,986 |
| Profit after taxes | € -5,883 | € 84,105 | € 110,894 | € 1,296,857 | ▲ € 1.2 million |
| Equity | € -4,883 | € 79,223 | € 190,117 | € 1,117 | ▼ 99% |
| Total debts | € 533,895 | € 468,292 | € 448,431 | € 252,314 | ▼ 44% |
| Cash | € 21,416 | € 30,562 | € 123,175 | € 9,341 | ▼ 92% |
| Retained profit | € -5,883 | € 78,223 | € 189,117 | € 117 | ▼ € 189,000 |
| Dividend | € 0 | € 0 | € 0 | € 1,485,857 | |
| Bank debt | € 358,168 | € 305,787 | € 248,011 | € 0 | ▼ 100% |
| Balance sheet total | € 529,012 | € 547,515 | € 638,548 | € 253,430 | ▼ 60% |
Key figures of RX FAVOREEL, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to RX FAVOREEL?
What happened at RX FAVOREEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 1.3 million (▲ € 1.2 million vs 2025). Source: NBB ↗
- New establishment in Destelbergen. KBO
- Niels Favoreel became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 5,883 loss in 2023 to € 1.3 million profit in 2026.
Paid € 64,794 in corporate taxes since 2023.
Best year ever: 2026, with € 1.3 million profit.
Paid out € 1.5 million in dividends to the owners in total.
A new publication or filing at RX FAVOREEL? We notify you, reason included.
Follow RX FAVOREELDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind RX FAVOREEL is Niels Favoreel. Niels Favoreel is also behind IATREION, Radiologie Dr. Favoreel, IMMORAD and RX Mariakerke.
Directors
According to the 2026 annual accounts
since 2022
Establishments
Establishment units
Physical locations of this company
Eenbeekstraat 68
9070 Destelbergen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0783.537.096
- VAT number
- BE 0783.537.096
- Registered office
- Eenbeekstraat 68, 9070 Destelbergen
- Names & denominations
- RX FAVOREEL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 March 2022
- Peppol
- Active · Active since 27 Mar 2026